Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Seminars in Hematology|June 25, 2009
Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemiaTimothy Jancel, Scott R PenzakJournal of Clinical Pharmacology|February 10, 2024
Phenibut: Review and Pharmacologic Approaches to Treating WithdrawalScott R Penzak, Marilyn BullochEuropean Journal of Drug Metabolism and Pharmacokinetics|November 20, 2016
Pharmacokinetic Drug Interactions with Panax ginsengMeenakshi R Ramanathan, Scott R PenzakAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Management of protease inhibitor-associated hyperlipidemiaScott R Penzak, Susan K ChuckExpert Review of Clinical Pharmacology|January 14, 2014
Pharmacological enhancement of protease inhibitors with ritonavir: an updateKristin H Busse, Scott R PenzakJournal of Clinical Pharmacology|February 13, 2019
4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical EvaluationScott R Penzak, Carlos Rojas-FernandezExpert Opinion on Drug Safety|August 9, 2003
Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemiaSusan K Chuck, Scott R PenzakCNS Drugs|June 3, 2018
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between AgentsMichael W Jann, Scott R PenzakCNS Drugs|March 24, 2018
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between AgentsMichael W Jann, Scott R PenzakAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 25, 2007
Darunavir: a second-generation protease inhibitorKristin H S Busse, Scott R PenzakPageof 8